GUIDO, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 2.301
EU - Europa 1.196
AS - Asia 993
SA - Sud America 281
AF - Africa 15
OC - Oceania 2
Totale 4.788
Nazione #
US - Stati Uniti d'America 2.283
SG - Singapore 586
IE - Irlanda 574
RU - Federazione Russa 259
BR - Brasile 247
HK - Hong Kong 241
IT - Italia 99
CN - Cina 95
DE - Germania 76
FI - Finlandia 36
CZ - Repubblica Ceca 25
GB - Regno Unito 20
BE - Belgio 19
SE - Svezia 19
FR - Francia 15
IN - India 12
IQ - Iraq 11
AR - Argentina 10
EC - Ecuador 10
CA - Canada 9
NL - Olanda 9
TR - Turchia 6
AT - Austria 5
BD - Bangladesh 5
BG - Bulgaria 5
JP - Giappone 5
LT - Lituania 5
AZ - Azerbaigian 4
EE - Estonia 4
ES - Italia 4
PL - Polonia 4
TN - Tunisia 4
UY - Uruguay 4
AL - Albania 3
CO - Colombia 3
EG - Egitto 3
IL - Israele 3
KZ - Kazakistan 3
MA - Marocco 3
OM - Oman 3
RS - Serbia 3
TW - Taiwan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CR - Costa Rica 2
IR - Iran 2
JM - Giamaica 2
NO - Norvegia 2
RO - Romania 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GL - Groenlandia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MX - Messico 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SI - Slovenia 1
TM - Turkmenistan 1
UA - Ucraina 1
Totale 4.788
Città #
Dublin 566
Chandler 556
Singapore 269
Hong Kong 240
Santa Clara 226
Jacksonville 139
Boardman 132
Lawrence 82
Princeton 82
Wilmington 81
New York 71
Des Moines 70
Ashburn 69
Moscow 60
Los Angeles 57
San Mateo 47
Ann Arbor 37
Falls Church 34
Munich 26
Dallas 23
Rome 23
Helsinki 22
Brussels 19
The Dalles 19
Brno 18
São Paulo 16
L’Aquila 14
Norwalk 12
Council Bluffs 11
Frankfurt am Main 10
Shanghai 10
Bremen 9
Lappeenranta 9
Mumbai 8
Brasília 7
Curitiba 7
Düsseldorf 7
Falkenstein 7
Hanover 7
Baghdad 6
Belo Horizonte 6
Gioiosa Ionica 6
Lauterbourg 6
Ravenna 6
Toronto 6
Bristol 5
Olomouc 5
Rio de Janeiro 5
Sofia 5
Stockholm 5
Tokyo 5
Baku 4
Campinas 4
Guayaquil 4
London 4
Montevideo 4
Phoenix 4
Pune 4
Tappahannock 4
Turku 4
Vienna 4
Warsaw 4
Amsterdam 3
Assago 3
Barbacena 3
Berlin 3
Betim 3
Caxias do Sul 3
Clifton 3
Edinburgh 3
Fairfield 3
Fremont 3
Goiânia 3
Houston 3
Madrid 3
Novo Hamburgo 3
Quito 3
Tallinn 3
Taubaté 3
Tel Aviv 3
Tunis 3
Araxá 2
Beijing 2
Belgrade 2
Cairo 2
Camaçari 2
Canoas 2
Carapicuíba 2
Dammam 2
Dubai 2
Fara San Martino 2
Florence 2
Fortaleza 2
Francavilla al Mare 2
Hangzhou 2
Istanbul 2
Jaboatão dos Guararapes 2
Jinan 2
Joinville 2
João Pessoa 2
Totale 3.307
Nome #
Acute insulin response to intravenous glucagon in polycystic ovary syndrome 91
Case report: incomplete Cauda Equina Syndrome following a caesarean section with spinal anaesthesia 79
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: Relationship with insulin secretion 78
Carbon dioxide in office diagnostic hysteroscopy: An open question. A multicenter randomized trial on 1982 procedures 76
Sex ratio at birth: causes of variation and narrative review of literature 74
ROLE OF VOCAL DISTRACTION ANALGESIA ON PAIN MANAGEMENT IN THE OFFICE HYSTEROSCOPY PROCEDURE: A RANDOMIZED CONTROLLED STUDY 70
Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndrome 68
Role of opioid antagonists in the treatment of women with glucoregulation abnormalities 66
Botulinum toxin in incontinent women with neurogenic bladder after failure with anticholinergic therapy, long-term results: a pilot study 66
Perinatal mental illness and autoimmune diseases: a qualitative sistematic review 65
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome 64
COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine 63
AGEs-related dysfunctions in PCOS: evidence from animal and clinical research 59
A first stage placental site trophoblastic tumor: a case report and review of literature 59
Perimesencephalic Subarachnoid Hemorrhage in Pregnancy 57
The Impact of Metal Nanoparticles on Female Reproductive System: Risks and Opportunities 56
DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer 56
How metformin acts in PCOS pregnant women: Insights into insulin secretion and peripheral action at each trimester of gestation 56
Sonographic features of pelvic tuberculosis mimicking ovarian-tubal-peritoneal carcinoma 53
Asymptomatic postmenopausal endometrial thickening: a comparison between transvaginal ultrasound and hysteroscopy in the diagnosis of intracavitary uterine pathologies 52
Comparison of absorbable and permanent sutures for laparoscopic sacrocervicopexy: A randomized controlled trial 52
Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase 52
Using a 16-french resectoscope as an alternative device in the treatment of uterine lesions: A randomized controlled trial 52
Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome 52
The effect of age on the ovarian response to gonadotropin and on pregnancy rate in polycystic ovary syndrome 51
Assessment of insulin resistance in lean women with polycystic ovary syndrome 51
Opioid blockade effect on insulin β-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus 51
Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: Effect of naloxone 51
Endocrinology: Effect of opioid blockade on insulin metabolism in polycystic ovarian disease 50
Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin 50
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? 50
Second stimulation in the same ovarian cycle: an option to fully-personalize the treatment in poor prognosis patients undergoing PGT-A 50
The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study 49
Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: Role of hyperinsulinism 49
A pilot study of the long-term effects of acipimox in polycystic ovarian syndrome 49
Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study 48
Ethinylestradio-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: Evaluation of the metabolic impact 48
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: A clinical, endocrinological, metabolic pilot study 48
Erratum: Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles (Fertility and Sterility (1994) 62 (35- 41)) 48
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 48
Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome 48
Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome 48
Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome 47
Differentiation of spermatogenic cells during in-vitro culture of testicular biopsy samples from patients with obstructive azoospermia: Effect of recombinant follicle stimulating hormone 47
Effect of metformin on the growth hormone response to growth hormone-releasing hormone in obese women with polycystic ovary syndrome 47
Metformin improves endothelial function in normoinsulinemic PCOS patients: A new prospective 47
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology 47
Effect of corticotropin-releasing factor on the pituitary-ovary axis in human luteal phase 47
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: A pilot prospective study 46
Follicular loss in endoscopic surgery for ovarian endometriosis: Quantitative and qualitative observations 46
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease 45
Expectant management may reduce overtreatment in women affected by unexplained infertility confirmed by diagnostic laparoscopy 44
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: A randomized double-blind placebocontrolled clinical trial 44
Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles 44
Sexual Function following Laparoscopic versus Transvaginal Closure of the Vaginal Vault after Laparoscopic Hysterectomy: Secondary Analysis of a Randomized Trial by the Italian Society of Gynecological Endoscopy Using a Validated Questionnaire 43
Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study 43
Vaginal mesh exposure after laparoscopic sacrocervicopexy performed with permanent or absorbable sutures 43
The Accuracy of Third-Trimester Ultrasound in Predicting Large for Gestational Age or Macrosomic Fetuses in Diabetic and Non-Diabetic Pregnant Women: A Systematic Review and Meta-Analysis 42
Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome 42
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome 42
Metformin treatment does not affect total leptin levels and free leptin index in obese patients with polycystic ovary syndrome 42
Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: A case report 42
Laparoscopic sacrocolpopexy versus pelvic organ prolapse suspension for surgical management of pelvic organ prolapse: a retrospective study 42
Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome 41
The Impact of Insulin Secretion on the Ovarian Response to Exogenous Gonadotropins in Polycystic Ovary Syndrome 41
The accuracy of prenatal cell-free DNA screening for sex chromosome abnormalities: a systematic review and meta-analysis 40
The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes 40
Hyperinsulinemia in PCOS. Possible role in the determination of the ovary response to gonadotrophins 40
Clinical efficacy andmetabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: A randomized study 40
Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome 40
Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome 40
Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome 40
Risk Assessment Model for Complications in Minimally Invasive Hysterectomy: A Pilot Study 39
Postmenarchal Down's syndrome: A theoretical model of growth hormone action on ovarian function 39
Fertility preservation methods in breast cancer 39
Synchronous ovarian and uterine tumours, case report of an unusual association 38
Pre-eclampsia: From Etiology and Molecular Mechanisms to Clinical Tools. A Review of the Literature 38
Ultrasound Features and Clinical Outcome of Patients with Ovarian Masses Diagnosed during Pregnancy: Experience of Single Gynecological Ultrasound Center 38
Human spermatogenesis in vitro: Respective effects of follicle- stimulating hormone and testosterone on meiosis, spermiogenesis, and sertoli cell apoptosis 38
The use of different size-hysteroscope in office hysteroscopy: Our experience 38
The Perception of the Quality of Professional Healthcare Assistance for the Management of Endometriosis: Findings from a National Survey in Italy 37
Sonographic characteristics of ovarian Leydig cell tumor 37
How should the best human embryo in vitro be? Current and future challenges for embryo selection 37
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome: Dexamethasone and GnRH-agonist administration 37
Favorable conception and pregnancy involving a male patient affected by chronic myeloid leukemia while taking dasatinib 37
Position paper on prevention of surgical site infections in obstetric and gynecological surgery 37
DTC chemotherapy regimen is associated with higher occurrence of premature ovarian failure in women of reproductive age with breast cancer 36
Shining light in a dark landscape: MRI evaluation of unusual localization of endometriosis 35
The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: An euglycaemic-hyperinsulinaemic clamp study 35
Nerve-Sparing Laparoscopic Colposacropexy Using a Percutaneous Surgical System: A Case Report 35
Metaphase‑II oocyte competence is unlinked to the gonadotrophins used for ovarian stimulation: a matched case–control study in women of advanced maternal age 34
Investigating Unhealthy Behaviors Associated with SF-36 Domains in Women with Endometriosis—Findings from a Web-Based Survey Data Set 34
Endocrinology: Differential androgen response to adrenocorticotrophin hormone stimulation and effect of opioid antagonist on insulin secretion in polycystic ovarian syndrome 34
The hypothalamic-pituitary-luteal axis in women: effects of long-term orally active opioid antagonist (naltrexone) administration 34
Clinical, obstetric and perinatal outcomes after vitrified-warmed euploid blastocyst transfer are independent of cryo-storage duration 34
Late third trimester diagnosis of congenital giant hemangioma complicated by the Kasabach-Merritt phenomen: a case report and literature review 34
Factors associated with chronic pelvic pain in women with endometriosis: A national study on clinical and sociodemographic characteristics, lifestyles, quality of life, and perceptions of quality of care, during the COVID-19 pandemic 32
Conservative management of preterm premature rupture of membranes < 30 weeks of gestational age: Effectiveness of clinical guidelines implementation strategies 32
Conservative Management and Ultrasound Follow-Up of Parasitic Myoma: Our Experience and Literature Review 31
Recurrent Metastatic Pulmonary Synovial Sarcoma during Pregnancy: A Case Report and Literature Review 30
Totale 4.696
Categoria #
all - tutte 31.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.176


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021265 0 0 0 0 0 0 0 70 75 2 117 1
2021/2022425 0 4 3 9 32 35 9 32 41 32 37 191
2022/20231.675 122 116 35 162 78 194 27 126 699 11 83 22
2023/2024480 71 17 43 34 33 110 22 35 3 51 22 39
2024/20252.124 53 48 174 148 298 280 331 125 553 107 7 0
Totale 4.969